The U.S. Food and Drug Administration (FDA) has announced that the recall was voluntarily initiated by the company, as a result of "CGMP [Current Good Manufacturing Practice] Deviations: Presence of N ...

The Cebu Provincial Government has signed a memorandum of agreement with the Department of Science and Technology and the Food and Drugs Administration to improve the quality of products produced by ...

and report compounded drugs to the FDA. The facilities must also comply with Current Good Manufacturing Practices ...

The Company’s fully integrated cell and gene therapy cGMP manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITAL™ trial, and is capable of supporting commercial ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and ...

Sight Care is an all-new vision support complex that has become a topic of discussion in the market over the past few ...

The FDA has lifted a clinical hold on Carsgen Therapeutics Holdings Ltd.’s.

so sites must reevaluate their quality and safety credentials and maintain a state of good manufacturing practice (GMP) readiness. Throughout the pandemic, the lack of FDA inspections has created ...

Indian contract research organizations (CROs) have become increasingly well-integrated with electronic systems as the US FDA issues new guidelines regarding electronic records and signatures in ...

Coriolis Pharma, a biopharma company specializing in R&D and GMP drug product development, recently announced the launch of a new U.S. entity and two novel platform services designed to accelerate ...

Hem Securities Ltd. is the book-running lead manager of the issue and Hem Finlease is the market maker. The grey market premium (GMP) on the Danish Power IPO was Rs 265 as of 8:28 p.m. on Oct. 22, ...